Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has issued an announcement.
Jiangsu Recbio Technology Co., Ltd. has announced its 2024 Annual General Meeting scheduled for June 20, 2025, where various resolutions will be considered, including financial reports, profit distribution plans, and changes in business scope. The meeting’s outcomes could significantly impact the company’s strategic direction and stakeholder interests, particularly with resolutions on share issuance and amendments to the Articles of Association.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the biotechnology industry, focusing on medical technology and innovation.
Average Trading Volume: 94,656
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.01B
For detailed information about 2179 stock, go to TipRanks’ Stock Analysis page.